Shares soar in Chinese drugmaker after positive COVID drug trials
Shares in the Chinese pharmaceutical group Kintor rocketed on Wednesday after it reported that trials had shown its COVID-19 drug to be highly effective, making it potentially China’s first homegrown antiviral treatment.